Compare GAME & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GAME | BTMD |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 39.0M |
| IPO Year | 2024 | 2021 |
| Metric | GAME | BTMD |
|---|---|---|
| Price | $2.63 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $11.33 | $2.61 |
| AVG Volume (30 Days) | 90.3K | ★ 116.4K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.14 | ★ 722.22 |
| EPS | N/A | ★ N/A |
| Revenue | $44,999,302.00 | ★ $192,219,000.00 |
| Revenue This Year | $91.12 | N/A |
| Revenue Next Year | $47.60 | $5.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $1.00 |
| 52 Week High | $3.85 | $3.26 |
| Indicator | GAME | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 36.45 |
| Support Level | $0.33 | N/A |
| Resistance Level | $3.85 | $1.68 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 6.67 | 38.46 |
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.